Howland Robert H
University of Pittsburgh, School of Medicine, Western Psychiatric Institute and Clinic, PA 15213, USA.
J Psychosoc Nurs Ment Health Serv. 2007 Jul;45(7):15-9. doi: 10.3928/02793695-20070701-06.
Suicidal thoughts are a symptom of depression, and completed suicide is a tragic complication of depressive illness. Although pharmacotherapy is effective for the treatment of depression, the U.S. Food and Drug Administration has ordered that all antidepressant medications carry a warning indicating that they are associated with an increased risk of suicidal thinking, feeling, and behavior in children, adolescents, and young adults. These warnings have received much attention in the general media and have caused much controversy and debate about the relative safety of these commonly used drugs and the appropriateness of their use, especially in younger patients. In this article, I will discuss this issue with the goal of putting the risk in perspective.
自杀念头是抑郁症的一种症状,而自杀身亡是抑郁性疾病的一种悲惨并发症。尽管药物疗法对抑郁症治疗有效,但美国食品药品监督管理局已下令,所有抗抑郁药物都要附上一则警示,表明它们会增加儿童、青少年及青年成年人出现自杀念头、自杀情绪和自杀行为的风险。这些警示在大众媒体上备受关注,引发了诸多关于这些常用药物的相对安全性及其使用合理性的争议和辩论,尤其是在较年轻患者群体中。在本文中,我将探讨这个问题,目的是正确看待这种风险。